PMID- 31767034 OWN - NLM STAT- MEDLINE DCOM- 20200916 LR - 20200916 IS - 1479-5876 (Electronic) IS - 1479-5876 (Linking) VI - 17 IP - 1 DP - 2019 Nov 25 TI - The pathogenesis of renal injury and treatment in light chain deposition disease. PG - 387 LID - 10.1186/s12967-019-02147-4 [doi] LID - 387 AB - Light chain deposition disease (LCDD) is a rare clinical disorder. The deposition of light chain immunoglobulins mainly affects the kidneys, which have different characteristics than other tissues. To date, the therapeutic approach for the treatment of LCDD has no evidence-based consensus, and clinical experience of reported cases guides current disease management strategies. The present systematic review investigates and summarizes the pathological mechanisms of renal injury and the subsequent treatments for LCDD. FAU - Wang, Qi AU - Wang Q AD - Department of Nephrology, The Second Affiliated Hospital of Nanchang University, No. 1, Minde Road, Donghu District, Nanchang, Zip Code: 330006, People's Republic of China. AD - Medical Center of the Graduate School, Nanchang University, Nanchang, China. FAU - Jiang, Fang AU - Jiang F AD - Department of Nephrology, People's Hospital of Xinyu City, No. 369, Xinxin North Avenue, High-tech District, Xinyu, People's Republic of China. FAU - Xu, Gaosi AU - Xu G AD - Department of Nephrology, The Second Affiliated Hospital of Nanchang University, No. 1, Minde Road, Donghu District, Nanchang, Zip Code: 330006, People's Republic of China. gaosixu@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20191125 PL - England TA - J Transl Med JT - Journal of translational medicine JID - 101190741 RN - 0 (Immunoglobulin Light Chains) SB - IM MH - Animals MH - Humans MH - Immunoglobulin Light Chains/*metabolism MH - Kidney/*injuries/pathology/ultrastructure MH - Models, Biological PMC - PMC6878616 OTO - NOTNLM OT - Biopsy OT - Chemotherapy OT - Light chain deposition disease OT - Renal injury OT - Treatment COIS- The authors declare that they have no competing interests. EDAT- 2019/11/27 06:00 MHDA- 2020/09/17 06:00 PMCR- 2019/11/25 CRDT- 2019/11/27 06:00 PHST- 2019/05/19 00:00 [received] PHST- 2019/11/19 00:00 [accepted] PHST- 2019/11/27 06:00 [entrez] PHST- 2019/11/27 06:00 [pubmed] PHST- 2020/09/17 06:00 [medline] PHST- 2019/11/25 00:00 [pmc-release] AID - 10.1186/s12967-019-02147-4 [pii] AID - 2147 [pii] AID - 10.1186/s12967-019-02147-4 [doi] PST - epublish SO - J Transl Med. 2019 Nov 25;17(1):387. doi: 10.1186/s12967-019-02147-4.